Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

Market Cap	11.75B +8.8%
Revenue (ttm)	2.74B -4.5%
Net Income	195.63M +6.4%
EPS	0.24 +6.4%
Shares Out	824.60M
PE Ratio	60.08
Forward PE	35.63
Dividend	0.08 (0.55%)
Ex-Dividend Date	n/a

Volume	35,673,526
Average Volume	23,561,859
Open	14.60
Previous Close	14.44
Day's Range	14.12 - 14.69
52-Week Range	12.05 - 18.68
Beta	0.01
RSI	55.97
Earnings Date	Mar 26, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,583
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002675

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.